Table 2.
Clinicopathological Characteristics Of HCC Patient Samples
| Characteristics | Number Of Cases(%) | CCT6A Expression | P value | |
|---|---|---|---|---|
| Low | High | |||
| Gender | 0.782 | |||
| Female | 17(12.8) | 11 | 6 | |
| Male | 116(87.2) | 71 | 45 | |
| Age | 0.243 | |||
| ≤50 | 83(62.4) | 48 | 35 | |
| >50 | 50(37.6) | 34 | 16 | |
| Encapsulation | 0.523 | |||
| Yes | 95(74.2) | 47 | 48 | |
| No | 33(25.8) | 19 | 14 | |
| Tumor size(cm) | 0.145 | |||
| ≤5 | 31(24.2) | 17 | 14 | |
| >5 | 97(75.8) | 49 | 48 | |
| Tumor number | 0.932 | |||
| Singe | 109(82.6) | 60 | 49 | |
| Multiple | 23(17.4) | 8 | 15 | |
| Metastasis | 0.517 | |||
| Yes | 13(9.8) | 7 | 6 | |
| No | 118(89.4) | 61 | 57 | |
| Cirrhosis | 0.909 | |||
| Negative | 27(20.5) | 15 | 12 | |
| Positive | 101(76.5) | 51 | 50 | |
| Thrombosis | 0.542 | |||
| Yes | 13(9.8) | 5 | 8 | |
| No | 119(90.2) | 63 | 56 | |
| Differentiation grade | 0.093 | |||
| Well | 8(6.3) | 5 | 3 | |
| Middle | 116(91.3) | 57 | 59 | |
| Poor | 3(2.4) | 2 | 1 | |
| TNM stage | 0.471 | |||
| Ⅰ | 95(72) | 53 | 42 | |
| Ⅱ+Ⅲ+Ⅳ | 37(28) | 15 | 22 | |
| Recurrence | 0.106 | |||
| Yes | 52(41.3) | 26 | 26 | |
| No | 74(58.7) | 40 | 34 | |
| ALT | 0.304 | |||
| ≤40 | 69(53.9) | 38 | 31 | |
| >40 | 59(46.1) | 28 | 31 | |
| Bilirubin(umol/L) | 0.374 | |||
| ≤17.1 | 67(52.3%) | 36 | 31 | |
| >17.1 | 61(47.7%) | 30 | 31 | |
| PT | 0.88 | |||
| ≤17 | 124(93.9) | 64 | 60 | |
| >17 | 3(2.3) | 2 | 1 | |
| AFP(ng/mL) | 0.063 | |||
| ≤200 | 63(49.6) | 37 | 26 | |
| >200 | 64(50.4) | 28 | 36 | |
| HBsAg | 0.723 | |||
| Negative | 16(12.1) | 11 | 5 | |
| Positive | 111(84.1) | 55 | 56 | |
| Survival | 0.032 | |||
| Died | 60(45.5) | 26 | 34 | |
| Alive | 72(54.5) | 42 | 30 | |